北生藥業(yè)股份有限公司短貸長(zhǎng)投財(cái)務(wù)異化行為治理研究
[Abstract]:With the rapid development of small and medium-sized enterprises in China, the hidden problems behind the development process are increasingly exposed. At present, most small and medium-sized enterprises have some problems, such as large short term loan gap, low success rate of medium and long term loans, serious shortage of endogenous funds, unreasonable capital structure and high financing cost, which lead to the rise of financial operation mode of short loan and long term investment. Under the current tight macro policy, there is nowhere to escape the problems of the superficial listed companies, and the financial alienation caused by the short loan and long investment is exposed. A series of phenomena, such as enterprise financial alienation, enterprise closing down, boss missing and so on, emerge in endlessly. Based on this background, Beisheng Pharmaceutical Co., Ltd. is the research object to study the governance of financial alienation behavior of short loan and long investment. On the basis of defining the related concepts such as short loan long investment, financial alienation behavior and so on, this paper expounds the theoretical basis of financial alienation behavior of short loan long investment from the angles of economics, management and behavioral finance. It is pointed out that the theoretical basis for the study on the governance of financial alienation behavior of short loan long cast in Beisheng Pharmaceutical Co., Ltd. makes the case analysis of short loan long cast financial alienation in Beisheng Pharmaceutical Industry persuasive. After laying the theoretical foundation, starting with the basic situation of Beisheng Pharmaceutical Co., Ltd., this paper analyzes the combination of quantitative and qualitative analysis, and analyzes why most private enterprises generally have the phenomenon of short loan and long investment. And find out the cause of financial alienation behavior of Beisheng Pharmaceutical Co., Ltd. Then from the macro economic environment, commercial banks and the company itself analysis of the Beisheng Pharmaceutical Co., Ltd. short loan long investment financial alienation behavior factors. On the basis of the combination of theory and case analysis, aiming at the influence factors of financial alienation behavior of short loan and long term investment in Beisheng Pharmaceutical Industry, through the perfection of external financing environment, The optimization of credit management mechanism and the improvement of corporate governance efficiency of commercial banks put forward the basic ideas to solve the problem of financial alienation of short loan and long investment in Beisheng Pharmaceutical Co., Ltd. In this study, the financial dissimilation behavior of short loan and long investment in Beisheng Pharmaceutical Co., Ltd was studied systematically and deeply. Through the specific analysis and research of Beisheng Pharmaceutical Company, the financial alienation behavior of short loan and long investment in small and medium-sized enterprises of our country is further studied, and the corporate governance system and financing system of our country are gradually perfected.
【學(xué)位授予單位】:哈爾濱商業(yè)大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2014
【分類(lèi)號(hào)】:F426.82;F406.7
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 宇靖;北生藥業(yè)股價(jià)與盈利增長(zhǎng)反向運(yùn)動(dòng)[J];證券導(dǎo)刊;2004年10期
2 葉檀;;北生藥業(yè):民企上市公司圈錢(qián)游戲的典型[J];董事會(huì);2008年12期
3 ;北生速救[J];新理財(cái);2011年01期
4 劉勘;;再融資搶趕末班車(chē) 類(lèi)別表決不該有“后門(mén)”[J];中國(guó)經(jīng)濟(jì)信息;2004年22期
5 洪海超;;關(guān)于G北生財(cái)務(wù)疑云的探討[J];今日科苑;2008年02期
6 ;精選資料庫(kù)[J];股市動(dòng)態(tài)分析;2004年37期
7 鐘禾;;醫(yī)藥板塊保持可持續(xù)發(fā)展[J];資本市場(chǎng);2002年09期
8 ;[J];;年期
9 ;[J];;年期
10 ;[J];;年期
相關(guān)重要報(bào)紙文章 前10條
1 廣義;北生藥業(yè)連續(xù)三年高成長(zhǎng)[N];醫(yī)藥經(jīng)濟(jì)報(bào);2004年
2 周邊;北生藥業(yè) 重大事項(xiàng)遭遇拍賣(mài)險(xiǎn)阻[N];證券時(shí)報(bào);2007年
3 記者 程霞;北生藥業(yè)“重生”[N];北海日?qǐng)?bào);2009年
4 習(xí)文;北生藥業(yè):產(chǎn)品經(jīng)營(yíng)資本運(yùn)營(yíng)比翼雙飛[N];醫(yī)藥經(jīng)濟(jì)報(bào);2002年
5 劉元坤 劉硯華;北生藥業(yè)一批新開(kāi)發(fā)的產(chǎn)品進(jìn)入申報(bào)階段[N];醫(yī)藥經(jīng)濟(jì)報(bào);2004年
6 廣義;北生藥業(yè):期待延續(xù)“倍增效應(yīng)”[N];醫(yī)藥經(jīng)濟(jì)報(bào);2004年
7 記者 王海洋;郡原地產(chǎn)借殼北生藥業(yè)落定[N];醫(yī)藥經(jīng)濟(jì)報(bào);2010年
8 葉信才;北生藥業(yè)募資見(jiàn)效非典增利[N];中國(guó)證券報(bào);2003年
9 東吳證券研究所;北生藥業(yè) 科技園貢獻(xiàn)大[N];中國(guó)證券報(bào);2004年
10 見(jiàn)習(xí)記者 韋承武;北生藥業(yè)定增募資投向智慧城市[N];上海證券報(bào);2014年
相關(guān)碩士學(xué)位論文 前1條
1 王雪玲;北生藥業(yè)股份有限公司短貸長(zhǎng)投財(cái)務(wù)異化行為治理研究[D];哈爾濱商業(yè)大學(xué);2014年
,本文編號(hào):2253320
本文鏈接:http://sikaile.net/jingjilunwen/kuaiji/2253320.html